Quality of life and antihypertensive effect with nebivolol and losartan.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Hypertension

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJHYPER.2005.03.733PMID 16296572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological properties of nebivolol in man

  2009cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study

  2003cited by this paper
• Antihypertensive Medication and Quality of Life—Silent Treatment of a Silent Killer?

  2002cited by this paper
• Losartan titration versus diuretic combination in type 2 diabetic patients

  2002cited by this paper
• ‘WHY DON'T YOU DO AS I TELL YOU?’ COMPLIANCE AND ANTIHYPERTENSIVE REGIMENS

  2002cited by this paper
• Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension: A Randomized, Double-Blind, Crossover Study

  2001cited by this paper
• P-249: A population-based study of compliance and persistency with cardiovascular agents used in hypertension management

  2001cited by this paper
• Health-related quality of life by disease and socio-economic group in the general population in Sweden.

  2001cited by this paper
• Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo

  2001cited by this paper
• Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study.

  2001cited by this paper
• A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.

  1999cited by this paper
• The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.

  1999cited by this paper
• Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide

  1999cited by this paper
• Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994.

  1998cited by this paper
• Self-rated health and mortality: a review of twenty-seven community studies.

  1997cited by this paper
• Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well‐being

  1997cited by this paper
• Quality of Life Comparison Between Bisoprolol and Nifedipine Retard in Hypertension

  1997cited by this paper
• Selective versus nonselective beta adrenoceptor antagonists in hypertension.

  1995cited by this paper
• Quality of Life and Antihypertensive Therapy in Men -- A Comparison of Captopril with Enalapril

  1993cited by this paper
• Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.

  1993cited by this paper
• Nebivolol in Hypertension: A Double‐Blind Placetbo‐Controlled Multicenter Study Assessing its Antihypertensive Efficacy and Impact on Quality of Life

  1993cited by this paper
• Quality of Life Perception During Antihypertensive Treatment: A Comparative Study of Bisoprolol and Enalapril

  1992cited by this paper
• Quality of life in hypertensives treated with atenolol or captopril: a double-blind crossover trial

  1992cited by this paper
• Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise?

  1992cited by this paper
• Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.

  1992cited by this paper
• Effect of antihypertensives on sexual function and quality of life: the TAIM Study.

  1991cited by this paper
• Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.

  1990cited by this paper
• The measurement of quality of life in hypertensive patients: a practical approach.

  1990cited by this paper
• The effects of antihypertensive therapy on the quality of life.

  1986cited by this paper

• Therapeutic management of erectile dysfunction: the AFU/SFMS guidelines.

  2024cites this paper
• Anti-hypertensive medications and erectile dysfunction: focus on β-blockers

  2024cites this paper
• Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis

  2024cites this paper
• Association Between Cardiovascular disease and Risk of Female Sexual Dysfunction: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials

  2024cites this paper
• Management of Hypertension with Female Sexual Dysfunction

  2022cites this paper
• Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysis

  2021cites this paper
• Update of the position paper on arterial hypertension and erectile dysfunction.

  2020cites this paper
• Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: A prospective, randomized, double-blind pilot study

  2020cites this paper
• Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis

  2020cites this paper
• Erectile dysfunction as a cardiovascular risk factor: time to step up?.

  2020cites this paper
• [Sexual dysfunction and antihypertensive treatment: Involvement of the different therapeutic classes and what to do about the treatment of hypertension].

  2019cites this paper
• Nebivolol in the Treatment of Arterial Hypertension.

  2019cites this paper
• Three Generations of β-blockers: History, Class Differences and Clinical Applicability.

  2019cites this paper
• An Open Label, Multi-Center, Non-Interventional Study of the Safety of Nebivolol (Nebilet) In the Treatment of Hypertension in Filipino Adult Patients: A Post Marketing Surveillance Study

  2018cites this paper
• Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials

  2018cites this paper
• Commento editoriale alle linee guida britanniche sull’ipertensione arteriosa 2006: “Hypertension: management of hypertension in adults in primary care. Partial update”

  2016cites this paper
• Erectile Function in Cardiovascular Disease and Hypertension: the Role of Nebivolol

  2016cites this paper
• Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol

  2016cites this paper
• Recent advances in the treatment of renal diseases with nebivolol: A literature review.

  2016cites this paper
• Quality of Life in Treatment-Resistant Hypertension

  2015cites this paper
• A Review of Nebivolol Pharmacology and Clinical Evidence

  2015cites this paper
• Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease.

  2014cites this paper
• Sexual Dysfunction Related to Drugs : A Critical

  2014cites this paper
• Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan

  2014cites this paper
• Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs

  2014cites this paper
• Contemporary use of β-blockers: clinical relevance of subclassification.

  2014cites this paper
• Let’s talk about sex

  2013cites this paper
• Quality of Life in Hypertensive Patients

  2013cites this paper
• Nebivolol: impact on cardiac and endothelial function and clinical utility

  2012cites this paper
• Nebivolol

  2012cites this paper
• Nebivolol

  2012cites this paper
• Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude

  2011cites this paper
• Nebivolol Lowers Blood Pressure and Increases Weight Loss in Patients With Hypertension and Diabetes in Regard to Age

  2010cites this paper
• Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study

  2010cites this paper
• Effects of valsartan and nebivolol on blood pressure, QT dispersion and left ventricular hypertrophy in hypertensive patients Hipertansif hastalarda valsartan ve nebivololun, kan basinci, QT dağilimi ve sol ventrikül hipertrofisi üzerine etkileri

  2010cites this paper
• Review: Update on Newer Antihypertensive Medicines and Interventions

  2010cites this paper
• Tolérance aux bêtabloquants: de nouveaux horizons?

  2010cites this paper
• Update on Newer Antihypertensive Medicines

  2010cites this paper
• Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study.

  2010cites this paper
• Beta receptor blocker and erectile function: nebivolol-light at the end of the tunnel

  2010cites this paper
• Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care

  2010cites this paper
• Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations

  2009cites this paper
• Are Tolerability Concerns a Class Effect of Beta-Blockers in Treating Patients with Hypertension?

  2009cites this paper
• Realities of Newer β‐Blockers for the Management of Hypertension

  2009cites this paper
• Recent Advances in Pharmacotherapy

  2009cites this paper
• Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. The QoLaN study

  2009cites this paper
• Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension

  2009cites this paper
• Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.

  2009cites this paper
• Quality of life in hypertension management using olmesartan in primary care.

  2008cites this paper
• Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.

  2008cites this paper
• Nebivolol: a new antihypertensive agent.

  2008influential citation
• Nebivolol/Hydrochlorothiazide

  2008cites this paper
• β-blockers in the management of hypertension: focus on nebivolol

  2008cites this paper
• Efficacy and Tolerability of Nebivolol Compared with Other Antihypertensive Drugs

  2008cites this paper
• Quality of life in hypertension management using olmesartan in primary care

  2008cites this paper
• Nebivolol: third-generation β-blockade

  2007cites this paper
• Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.

  2007cites this paper
• A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.

  2007cites this paper
• The editor's roundtable: revisiting the role of beta blockers in hypertension.

  2007cites this paper
• The Changing Landscape of Hypertension and the Evolving Role of Vasodilatory Beta-Blockers

  2007cites this paper
• Pharmacoeconomic Benefits of Antihypertensive Therapy

  2007cites this paper
• 20 - Antihypertensive drugs

  2007cites this paper
• A Randomized, Double‐Blind, Placebo‐Controlled Parallel‐Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β‐Blocker, in Patients With Mild to Moderate Hypertension

  2007cites this paper
• A review of the safety and efficacy of nebivolol in the mildly hypertensive patient

  2007cites this paper
• A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertension.

  2007cites this paper
• Blood Pressure-Lowering Effect of Nebivolol in Hypertensive Patients with Type 2 Diabetes Mellitus

  2007cites this paper
• The Influence of prolonged β-blockers treatment on male rabbit's sexual behavior and penile microcirculation

  2007cites this paper
• Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation

  2006cites this paper
• Nebivolol: its role in the treatment of hypertension and chronic heart failure

  2006cites this paper